Nasrazadani, Azadeh
Tidwell, Rebecca S.
Kai, Megumi
Lim, Bora
Valero, Vicente
Tripathy, Debu
Saleem, Sadia
Debeb, Bisrat G.
Lucci, Anthony
Woodward, Wendy A.
Layman, Rachel M.
,
Layman, Rachel
Stauder, Michael C.
Sun, Susie X.
Whitman, Gary J.
Patel, Miral
Le-Petross, Huong
Lu, Yang
Marx, Angela
Alexander, Angela
Yajima, Chasity
Villareal, Lily
Lopez, Heather
Funding for this research was provided by:
NCI (State of Texas Grant for Rare and Aggressive Breast Cancer. Supported in part by Cancer Center Support (Core) Grant P30 CA016672)
Komen OG (250001)
BCRF
MDA/UT Austin Accelerator Grant
The IBC Network Foundation
Article History
Received: 11 June 2025
Accepted: 23 October 2025
First Online: 10 December 2025
Declarations
:
: All patients consented to participate in a prospective IRB-approved IBC registry protocol to collect data and biospecimens. The specific analysis of the data in the registry for this study was further approved via a separate IRB-approved protocol.
: Not applicable.
: The authors declare no competing interests.